HEXIM2 is a transcriptional regulator functioning as a general RNA polymerase II transcription inhibitor 12. It serves as a core component of the 7SK ribonucleoprotein (RNP) complex, where it cooperates with 7SK snRNA to sequester P-TEFb (positive transcription elongation factor b) in an inactive state, preventing RNA polymerase II C-terminal domain phosphorylation and blocking transcriptional elongation 12. HEXIM2 binds the 7SK hairpin loop region (nucleotides 23-88) with high affinity and forms stable homo- and hetero-oligomers, likely dimers, with HEXIM1 34. The inactive P-TEFb complex contains one 7SK molecule, a HEXIM dimer, and two P-TEFb molecules 4. HEXIM1 and HEXIM2 exhibit functionally redundant but tissue-specific expression patterns; HEXIM2 can compensate for HEXIM1 loss to maintain balanced active/inactive P-TEFb ratios controlling global transcription and cell growth 12. Beyond transcriptional control, HEXIM2 has shown associations with disease susceptibility, including a positive causal relationship with Type 2 diabetes mellitus 5 and potential involvement in esophageal cancer prognosis 6 and glioma progression 7. These findings establish HEXIM2 as a critical regulator of transcriptional elongation with broader roles in metabolic and oncologic disease pathogenesis.